Rick Hawkins
About
Rick Hawkins is from Austin, TX. Rick is currently Chairman & CEO at Lumos Pharma, located in Austin, Texas, United States. Rick also works as CEO & President at id2 - Innovations in Drug Development, a job Rick has held since Jan 1994.
Rick Hawkins's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Rick Hawkins's current jobs
Rick Hawkins is Chief Executive Officer, President and Chairman of Lumos Pharma. Lumos Pharma’s clinical development program will initially focus on its lead product candidate LUM-201, an oral growth hormone stimulating therapeutic in clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an alternative to the injections that current PGHD patients endure for many years of treatment. Mr. Hawkins currently serves as a Director for Plus Therapeutics (PSTV) and Savara Pharmaceuticals (SVRA). Mr. Hawkins was inducted into the Hall of Honor for the College of Natural Sciences at the University of Texas. In 2006 he received Ohio University’s Distinguished Business Achievement Award and was named on the top 10 Life Sciences CEO’s in Texas by the Texas Healthcare & Bioscience Institute. He is a member of the National Ernst and Young Entrepreneur of the Year Hall of Fame. In 2015, he received Ohio University’s Konneker Medal, the highest award given to a faculty member or former student for entrepreneurial excellence. Mr. Hawkins resides in Austin, Texas and maintains a residence near Columbus, Ohio. Mr. Hawkins has served on the Lumos Pharma Board since 2012 and Chairman since March 2020.
A pharmaceutical and biotechnology research management company located in Austin Texas. During this time he has served as an adviser and mentor in the start-up of numerous companies, including Sensus Drug Development Corporation. Sensus, a biotechnology company, developed Growth Hormone Antagonists for use in acromegaly, the complications of diabetes, and regulation of growth hormone in the treatment of specific types of tumors. Mr. Hawkins co-founded Sensus and served as the Charmain, prior to Sensus being sold to Pfizer. In addition, Mr. Hawkins was co-founder and Director of Covance Biotechnology Services, Inc., a full service contract manufacturer of recombinant proteins located in Research Triangle Park, NC. Covance was sold to Akzo Nobel, Inc. in early 2001. Mr. Hawkins served as Chairman of the Board for LoopOne, Inc., a shipping and logistics software company that provided state-of-the-art software systems for shipping, mailing, and logistics. LoopOne was purchased by Neopost of Paris, France in May 2001.